ROR1 and hematopoietic and lymphoid system neoplasm: Because immunosuppression and hematologic malignancies are established risk factors for cSCC and ROR1 is known to be overexpressed in several hematologic neoplasms, we additionally assessed whether ROR1 expression was enriched in patients with hematologic malignancies.